The Karolinska Kidney Research Center – KaroKidney – is a translational kidney research cluster based in Stockholm, Sweden. KaroKidney promotes programs for synergistic collaborations between basic and clinical researchers that will lead to discoveries and better healthcare strategies aimed at improving outcome for patients with kidney disease.
Read more.
KaroKidney's expanding biobank currently contains more than 700 renal biopsies (>400 native kidney biopsies from adult patients, 150 pediatric patients, 180 living donors and > 50 transplanted patients) and >200 arterial biopsies from patients with ESRD and healthy controls. The tissue is stored in ways that allows analysis of both morphology and RNA/protein expression.
Read more.
Next meeting will be held on April 27, at 3.00 pm.
New publications. See the latest
publications using material from KaroKidney
ERA-EDTA 2019. Join KaroKidney to Budapest for ERA-EDTA Annual Congress June 13-16. Read more
here
INTRICARE. Peter Stenvinkel from KaroKidney is part of the INTRICARE network, a EU financed research network within Horizon 2020. Read more
here
(article in Swedish) and
here (article in English).
KaroKidney is a collaboration between researchers from Karolinska Institutet, Karolinska University Hospital, SciLifeLab and Karolinska Institutet/AstraZeneca Integrated Cardio Metabolic Centre (ICMC) in Stockholm, Sweden. For more information, visit each institutions website.
Read more
